India to Brazil: Fluticasone Export Trade Route

The India to Brazil Fluticasone corridor is one of India's established pharmaceutical export routes, with 42 shipments documented worth a combined $5.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's fluticasone manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $125.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with fluticasone's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 32.0%, placing it at rank #5 among India's top fluticasone export destinations globally.

On the import side, key buyers of Indian fluticasone in Brazil include MYLAN BRASIL DISTRIBUIDORA DE MEDIC, MYLAN BRASIL DISTRIBUIDORA DE MEDI, VIATRIS BRASIL IMPORTADORA E DISTRI and 4 others. MYLAN BRASIL DISTRIBUIDORA DE MEDIC is the single largest importer with 15 shipments valued at $1.9M USD.

India's fluticasone exports to Brazil are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 36 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $125.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as dymista trade pack azelastine 137 mcg fluticasone propionate 50 mcg dymista trade pack 17ml 120 sprays br 400543629 and dymista trade pack (azelastine 137 mcg+fluticasone propionate 50 mcg);dymista trade pack - 17ml/ 120 sprays -br - 400543, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN BRASIL DISTRIBUIDORA DE MEDIC is the largest importer with 15 shipments worth $1.9M USD — representing 35% of all fluticasone imports from India on this route. A total of 7 buyers are active on this corridor.